Overview
Sclerosis denotes the abnormal hardening of tissue through scarring, fibrosis, or gliosis, and in neurology the term is most closely associated with multiple sclerosis, a chronic immune-mediated disease of the central nervous system in which inflammatory demyelination and axonal loss produce disseminated lesions in the brain, optic nerves, and spinal cord. Clinically, multiple sclerosis follows relapsing-remitting and progressive courses, presenting with optic and cranial nerve involvement, sensory and motor deficits, and accumulating disability quantified by validated severity measures. Research in this domain addresses pediatric-onset disease, neurovascular reactivity following relapses, and the prognostic factors governing disability progression in defined cohorts. Therapeutic and rehabilitative investigation spans phototherapy interventions such as ultraviolet B, evidence-based occupational therapy for rehabilitation, and coping strategies among affected individuals during periods of heightened vulnerability such as the COVID-19 pandemic, including questions of vaccine safety in this population. Related neuroinflammatory entities, including post-infectious acute disseminated encephalomyelitis, fall within the broader differential. Methodological work on blinding in neurological clinical research further informs trial design. The journal publishes peer-reviewed clinical cohort studies, case reports, rehabilitation research, and therapeutic trials addressing multiple sclerosis and related demyelinating disorders, their disability outcomes, and management strategies.
Research published in this journal
12 peer-reviewed articles, ranked by relevance. Each links to its DOI.
Neurovascular Reactivity after Repeated Attacks in Patients with Multiple Sclerosis
Safety of BBIBP-CorV (Sinopharm) COVID-19 Vaccination in People With Multiple Sclerosis: A Report From Iran
Ultraviolet B Phototherapy Intervention in Patients with Multiple Sclerosis: A Prospective, Randomized Pilot Trial
Fragiles but Resilient. The Key Strategies to Cope with Pandemic in Persons with Multiple Sclerosis. A Controlled Web Survey
Characterization of the Consciousness Energy Healing Treated Cholecalciferol Using LC-MS and GC-MS Spectrometry
Disability and prognostic factors of MS severity: An Algerian cohort study
Post-Covid-19 Acute Disseminated Encephalomyelitis (ADEM) in a 27-year-old girl: Case Report
The Early Use of Blinding in Therapeutic Clinical Research of Neurological Disorders
Why Music in Neurology?
Understanding Ubl-Rpn1 Intermolecular Interaction
How this research is being cited
The 12 articles above have been cited 15 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.
-
2026 · Photochemical & Photobiological Sciences
-
2025 · Photochemical & Photobiological Sciences
-
Uwe Riedmann et al. · 2025 · Photochemical and Photobiological Sciences
-
2024 · Pharmaceuticals
-
2024 · Pharmaceuticals
-
2023 · Research Square (Research Square)
-
2022 · Scholars Journal of Medical Case Reports
-
2022 · International Journal of Peptide Research and Therapeutics
A sample of recent works citing this journal's research on Sclerosis, linking to each citing work.